Saarbrücken/ Frankfurt a. Main — Silver Investment Partners (SIP) acquires specialty pharmaceutical distributor Lucien Ortscheit. King & Wood Mallesons (KWM) advised Silver Investment Partners (SIP) on the acquisition of a majority stake in Lucien Ortscheit GmbH (Lucien Ortscheit).
Lucien Ortscheit, based in Saarbrücken, Germany, is a leading international specialty pharmaceutical distributor with a focus on unlicensed medicines and clinical trial comparators. The company trades worldwide in medicines that are temporarily unavailable or unapproved in the target country. Lucien Ortscheit was founded in 1963 and taken over by the Kloos family in 2002. Since its foundation, the company has steadily developed and today already counts several thousand customers from over 60 countries among its widely diversified and loyal customer base.
SIP is an independent investor for equity financing of medium-sized companies in Germany, Austria and Switzerland. As an entrepreneurial, experienced and reliable partner, SIP is involved in majority and minority investments in companies with sales between 5 and 100 million euros, with a focus on companies with sales between 10 and 50 million euros.
The previous owners, the Kloos family, will retain a minority stake in the company. Mr. Kloos will continue to be responsible for the operational business as Managing Director in the medium term. SIP supports Lucien Ortscheit’s sustainable growth strategy. To further develop the company, growth opportunities such as international expansion, expansion of the product range and further suitable acquisitions in the national and international attractive niche market are to be exploited.
Advisors Silver Investment Partners: King & Wood Mallesons
Dr. Michael Roos (Partner), Dr. Peter Polke (Counsel), Dr. Katrin Thoma (Associate), Lorenz Liebsch (Associate), Simon Brandt (PSL) (all Corporate/M&A);
Markus Hill (Partner), Viktoria Rosbach (Associate) (both Tax)